BRPI0822264A2 - Dapsona para tratar rosácea - Google Patents
Dapsona para tratar rosáceaInfo
- Publication number
- BRPI0822264A2 BRPI0822264A2 BRPI0822264-9A2A BRPI0822264A BRPI0822264A2 BR PI0822264 A2 BRPI0822264 A2 BR PI0822264A2 BR PI0822264 A BRPI0822264 A BR PI0822264A BR PI0822264 A2 BRPI0822264 A2 BR PI0822264A2
- Authority
- BR
- Brazil
- Prior art keywords
- dapsona
- rose
- treat
- treat rose
- Prior art date
Links
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2008/002549 WO2009108147A1 (en) | 2008-02-27 | 2008-02-27 | Dapsone to treat rosascea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0822264A2 true BRPI0822264A2 (pt) | 2014-09-30 |
Family
ID=41016365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0822264-9A2A BRPI0822264A2 (pt) | 2008-02-27 | 2008-02-27 | Dapsona para tratar rosácea |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8586010B2 (enExample) |
| EP (1) | EP2249765B1 (enExample) |
| JP (1) | JP2011513304A (enExample) |
| AU (1) | AU2008351422A1 (enExample) |
| BR (1) | BRPI0822264A2 (enExample) |
| CA (1) | CA2714674A1 (enExample) |
| ES (1) | ES2775825T3 (enExample) |
| WO (1) | WO2009108147A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110152379A1 (en) * | 2008-07-25 | 2011-06-23 | Sang Chul Park | Composition for control of aging and/or extension of life, containing dapsone as active ingredient |
| MX2009004635A (es) * | 2009-04-29 | 2010-10-29 | Univ Autonoma Metropolitana | Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades. |
| JP5908884B2 (ja) * | 2010-03-15 | 2016-04-26 | ヴァージニア コモンウェルス ユニヴァーシティＶｉｒｇｉｎｉａ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｕｎｉｖｅｒｓｉｔｙ | 気道炎症及び粘液線毛輸送機能異常治療用のエアロゾル化したダプソン |
| KR101875705B1 (ko) | 2011-12-07 | 2018-07-06 | 삼성전자주식회사 | 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물 |
| US11039962B2 (en) | 2012-04-02 | 2021-06-22 | TurnCare, Inc. | Non-invasive pressure-mitigation apparatuses for improving blood flow and associated systems and methods |
| US20130255699A1 (en) | 2012-04-02 | 2013-10-03 | TurnCare, Inc. | Patient-orienting alternating pressure decubitus prevention support apparatus |
| DK2922528T3 (en) * | 2012-11-20 | 2017-09-18 | Allergan Inc | TOPICAL DAPSON AND DAPSON / ADAPALEN COMPOSITIONS AND PROCEDURES FOR USE THEREOF |
| US12178949B2 (en) | 2020-10-09 | 2024-12-31 | TurnCare, Inc. | Pressure-mitigation apparatuses for improved treatment of immobilized patients and associated systems and methods |
| US12016812B2 (en) | 2020-10-09 | 2024-06-25 | TurnCare, Inc. | Pressure-mitigation apparatuses for improved treatment of respiratory illnesses and associated systems and methods |
| JPWO2022269665A1 (enExample) * | 2021-06-21 | 2022-12-29 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3419009A1 (de) | 1984-05-22 | 1985-11-28 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel |
| DE3603577A1 (de) | 1986-02-06 | 1987-08-13 | Joachim K Prof Dr Seydel | Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit |
| US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US20030157036A1 (en) * | 2002-02-20 | 2003-08-21 | Osborne David W. | Topical dapsone for the treatment of acne |
| US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
| US6248324B1 (en) | 1997-10-31 | 2001-06-19 | Vincent Fischetti | Bacterial phage associated lysing enzymes for treating dermatological infections |
| US6254866B1 (en) | 1997-10-31 | 2001-07-03 | New Horizons Diagnostics Corporation | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
| US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| US6056955A (en) | 1999-09-14 | 2000-05-02 | Fischetti; Vincent | Topical treatment of streptococcal infections |
| WO2002085387A2 (en) * | 2001-04-23 | 2002-10-31 | Nucryst Pharmaceuticals Corp. | A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions |
| US20060204526A1 (en) * | 2003-08-13 | 2006-09-14 | Lathrop Robert W | Emulsive composition containing Dapsone |
| AU2004264964A1 (en) * | 2003-08-13 | 2005-02-24 | Qlt Usa, Inc. | Emulsive composition containing dapsone |
| FR2866570B1 (fr) * | 2004-02-20 | 2007-08-24 | Galderma Res & Dev | Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee |
| WO2007002447A2 (en) * | 2005-06-23 | 2007-01-04 | Bioform Medical, Inc. | Compositions for treating rosacea |
| PT2056813E (pt) * | 2006-08-16 | 2013-08-23 | Amderma Pharmaceuticals Llc | Compostos de 2,5-di-hidroxibenzeno para o tratamento da rosácea |
-
2008
- 2008-02-27 ES ES08726129T patent/ES2775825T3/es active Active
- 2008-02-27 CA CA2714674A patent/CA2714674A1/en not_active Abandoned
- 2008-02-27 JP JP2010548648A patent/JP2011513304A/ja active Pending
- 2008-02-27 WO PCT/US2008/002549 patent/WO2009108147A1/en not_active Ceased
- 2008-02-27 AU AU2008351422A patent/AU2008351422A1/en not_active Abandoned
- 2008-02-27 EP EP08726129.3A patent/EP2249765B1/en active Active
- 2008-02-27 BR BRPI0822264-9A2A patent/BRPI0822264A2/pt not_active Application Discontinuation
- 2008-02-27 US US12/305,413 patent/US8586010B2/en active Active
-
2013
- 2013-10-25 US US14/063,841 patent/US9504661B2/en active Active
-
2016
- 2016-11-28 US US15/362,099 patent/US20170071882A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011513304A (ja) | 2011-04-28 |
| WO2009108147A1 (en) | 2009-09-03 |
| ES2775825T3 (es) | 2020-07-28 |
| EP2249765A1 (en) | 2010-11-17 |
| US20100310480A1 (en) | 2010-12-09 |
| CA2714674A1 (en) | 2009-09-03 |
| EP2249765B1 (en) | 2019-11-13 |
| AU2008351422A1 (en) | 2009-09-03 |
| US9504661B2 (en) | 2016-11-29 |
| US8586010B2 (en) | 2013-11-19 |
| US20170071882A1 (en) | 2017-03-16 |
| EP2249765A4 (en) | 2012-09-05 |
| US20140050680A1 (en) | 2014-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| BRPI0922845A2 (pt) | pirazol-4-n-alcoxicarboxamidas como microbiocidas | |
| BRPI0914614A2 (pt) | 2-arilaminoquinazolinas para tratar doenças proliferativas | |
| SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
| BRPI0912026A2 (pt) | formulação homeopática | |
| BRPI0914781A2 (pt) | Microbiocidas | |
| BRPI0908428A2 (pt) | uso de ranozalina para tratar a dor. | |
| FIC20240018I1 (fi) | Vamoroloni | |
| BRPI0910208A2 (pt) | umidificador em linha | |
| BRPI1011226A2 (pt) | métodos para tratar condições relacionadas ao cabelo | |
| BRPI0919127A2 (pt) | métodos para tratamento de água | |
| BRPI0822264A2 (pt) | Dapsona para tratar rosácea | |
| BRPI1008253A2 (pt) | Metoso para tratar biomassa | |
| BRPI0819633A2 (pt) | Métodos para produzir poliolefinas | |
| BR112013008528A2 (pt) | métodos para tratar psoríase | |
| BRPI0921679A2 (pt) | composto útil para tratar celulite | |
| BRPI1006968A2 (pt) | microbiocidas | |
| BRPI0911199A2 (pt) | microbiocidas | |
| HRP20160577T1 (hr) | Liječenje osteoartritisa | |
| BRPI0908014A2 (pt) | método para tratar cabelo | |
| DK2173197T3 (da) | Fremgangsmåde | |
| BRPI0922216A2 (pt) | tratamento para glomerulonefrite | |
| BRPI1008155A2 (pt) | método para tratar câncer | |
| BRPI0909764A2 (pt) | compostos terapêuticos | |
| EP2266520A4 (en) | Massage machine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |